The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Phosphatase and Tensin Homology Deleted on Chromosome 10 Inhibitors Promote Neural Stem Cell Proliferation and Differentiation
Abstract
Phosphatase and tensin homology deleted on chromosome 10 (PTEN) is a tumor suppressor gene. Its encoded protein has phosphatase and lipid phosphatase activities, which regulate the growth, differentiation, migration, and apoptosis of cells. The catalytic activity of PTEN is crucial for controlling cell growth under physiological and pathological conditions. It not only affects the survival and proliferation of tumor cells, but also inhibits a variety of cell regeneration processes. The use of PTEN inhibitors is being explored as a potentially beneficial therapeutic intervention for the repair of injuries to the central nervous system. PTEN influences the proliferation and differentiation of NSCs by regulating the expression and phosphorylation of downstream molecular protein kinase B (Akt) and the mammalian target of rapamycin (mTOR). However, the role of PTEN inhibitors in the Akt/mTOR signaling pathway in NSC proliferation and differentiation is unclear. Dipotassium bisperoxo (picolinoto) oxovanadate (V) [bpv(pic)] is a biologically active vanadium compound that blocks PTEN dephosphorylation and suppresses its activity, and has been used as a PTEN lipid phosphatase inhibitor. Here, bpv(pic) intervention was found to significantly increase the number of rat NSCs, as determined by bromodeoxyuridine staining and the cell counting kit-8, and to increase the percentage of neurons undergoing differentiation, as shown by immunofluorescence staining. Bpv(pic) intervention also significantly increased PTEN and mTOR expression, as shown by real-time PCR analysis and western blotting. In conclusion, PTEN inhibitor bpv(pic) promotes the proliferation and differentiation of NSCs into neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PTEN is also a well-characterized negative regulator of the PI3K/Akt pathway. Downregulation of PTEN leads to increased phosphorylation of Akt and mTOR, which promotes NSCs Proliferation and Differentiation [63, 64].”
From M2 microglia-derived small extracellular vesicles modulate NSC fate after ischemic stroke via miR-25-3p/miR-93-5p-TGFBR/PTEN/FOXO3 axis (2025) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The activation of Akt/PKB signaling pathway and cell survival
Song, G., Ouyang, G., & Bao, S. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00337.x · Cited by 1,888
Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., Xu, B., Connolly, L., Kramvis, I., Sahin, M., et al. (2008) · Science · doi:10.1126/science.1161566 · Cited by 1,686
Tenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,034
Chappell, W. H., Steelman, L. S., Long, J. M., Kempf, R. C., Abrams, S. L., Franklin, R. A., Bäsecke, J., Stivala, F., Donia, M., Fagone, P., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.240 · Cited by 510
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis
Yamada, K. M., & Araki, M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2375 · Cited by 479
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
Hamada, K., Sasaki, T., Koni, P. A., Natsui, M., Kishimoto, H., Sasaki, J., Yajima, N., Horie, Y., Hasegawa, G., Naito, M., et al. (2005) · Genes & Development · doi:10.1101/gad.1308805 · Cited by 287
PTEN/mTOR and axon regeneration
Park, K. K., Liu, K., Hu, Y., Kanter, J. L., & He, Z. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.032 · Cited by 284
PTEN Counteracts FBXL2 to Promote IP3R3- and Ca2+-Mediated Apoptosis Limiting Tumour Growth
Kuchay, S., Giorgi, C., Simoneschi, D., Pagan, J., Missiroli, S., Saraf, A., Florens, L., Washburn, M. P., Collazo-Lorduy, A., Castillo-Martin, M., et al. (2017) · Nature · doi:10.1038/nature22965 · Cited by 251
Roles of autophagy and mTOR signaling in neuronal differentiation of mouse neuroblastoma cells
Zeng, M., & Zhou, J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.11.015 · Cited by 140
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
Thellung, S., Corsaro, A., Nizzari, M., Barbieri, F., & Florio, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040901 · Cited by 120
Li, D., Qu, Y., Mao, M., Zhang, X., Li, J., Ferriero, D. M., & Mu, D. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.102 · Cited by 101
Self-citationJung, K., Kim, M., So, J., Lee, S., Ko, S., & Shin, D. (2020) · Hepatology · doi:10.1002/hep.31679 · Cited by 82
Characterisation of the PTEN inhibitor VO-OHpic
Mak, L. H., Vilar, R., & Woscholski, R. (2010) · Journal of Chemical Biology · doi:10.1007/s12154-010-0041-7 · Cited by 81
PLD regulates myoblast differentiation through the mTOR-IGF2 pathway
Yoon, M.-S., & Chen, J. (2008) · Journal of Cell Science · doi:10.1242/jcs.022566 · Cited by 67 · cited 1×
“…of downstream effector molecules (Kuchay et al., 2017). mTOR is one such signal molecule in the PTEN signaling pathway, which is activated through phosphorylation and mediates a series of downstream molecules to promote the synthesis of cellular proteins and cell growth (Yoon and Chen, 2008).”
BackgroundPotentials of endogenous neural stem cells in cortical repair
Saha, B., Jaber, M., & Gaillard, A. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00014 · Cited by 64
Feng, Q., Li, X., Qin, X., Cheng, Y., Jin, Y. J., & Qian, X. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00241-8 · Cited by 61
Bisperoxovandium (pyridin‐2‐squaramide) targets both PTEN and ERK1/2 to confer neuroprotection
Zhang, Z., Chen, J., Han, X., Zhang, Y., Liao, H., Lei, R., Zhuang, Y., Wang, Z., Li, Z., Chen, J., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13727 · Cited by 50
Winbanks, C. E., Grimwood, L., Gasser, A., Darby, I. A., Hewitson, T. D., & Becker, G. J. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.08.004 · Cited by 44
Nguyen, L. H., & Anderson, A. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21656-8 · Cited by 39
Recent advances in PTEN signalling axes in cancer
Chow, J. T.-S., & Salmena, L. (2020) · Faculty Reviews · doi:10.12703/r/9-31 · Cited by 30
Guan, C., Luan, L., Li, J., & Yang, L. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147576 · Cited by 27
Self-citationLi, F., Li, P., Li, L., Deng, Y., Hu, Y., & He, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.608544 · Cited by 25
Chen, J., Debebe, A., Zeng, N., Kopp, J. L., He, L., Sander, M., & Stiles, B. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-90958-1 · Cited by 25
Que, J., Lian, Q., Oakley, R. M. E., Lim, B., & Lim, S. K. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-9 · Cited by 24
Lu, T., Wang, P., Liang, Y., Li, M., Li, D., Du, K.-H., Zhu, J., & Wu, J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.085 · Cited by 18
Lu, H., Han, X., Ren, J., Ren, K., Li, Z., & Zhang, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15967 · Cited by 17
Targeting PTEN to regulate autophagy and promote the repair of injured neurons
Yu, H., Shao, J., Huang, R., Guan, Y., Li, G., Chen, S., Fei, Z., Yao, Q., & Shen, J. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.10.008 · Cited by 12
Self-citationJia, J., Wang, M., Liu, M., Tan, Z., Cui, Y. T., & Yu, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.621187 · Cited by 10
Self-citationIdentifying Endogenous Neural Stem Cells in the Adult Brain In Vitro and In Vivo: Novel Approaches
Rueger, M. A., & Androutsellis‐Theotokis, A. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360010 · Cited by 8
Diet induces hepatocyte protection in fatty liver disease via modulation of PTEN signaling (Review)
Ikeda, Y., Murakami, M., Nakagawa, Y., Tsuji, A., Kitagishi, Y., & Matsuda, S. (2020) · Biomedical Reports · doi:10.3892/br.2020.1299 · Cited by 6
Guan, Y., Yang, F., Yao, Q. Z., Shi, J., Wang, G., Gu, Z., Fei, Z., & Shen, J. (2015) · Europe PMC (PubMed Central) · Cited by 3
Self-citation
Cited by
Zhang, Q., Yi, Y., Chen, T., Ai, Y., Chen, Z., Liu, G., Tang, Z., Chen, J., Xu, T., Chen, X., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03390-2 · Cited by 27
Metadata
- Authors
- Liu, X., Cui, Y., Li, J., Guan, C., Cai, S., Ding, J., Shen, J., & Guan, Y.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-14
- Volume
- 13
- ISSN
- 1663-9812
- PMC
- PMC9237411
- Cited by
- 9
- References
- 31
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.